Incyte Corporation
INCYNASDAQHealthcare● Active
$104.54
+$2.16(+2.11%)
Market Cap$20.9B
P/E Ratio—
52W High$112.29
52W Low$66.74
Incyte Corporation (INCY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · INCY · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B |
| Cost of Revenue | $0.37B | $0.31B | $0.25B | $0.21B | $0.15B |
| Gross Profit | $4.77B | $3.93B | $3.44B | $3.19B | $2.84B |
| Gross Margin %(computed) | 92.76% | 92.64% | 93.10% | 93.90% | 94.94% |
| Operating Expenses | |||||
| R&D Expenses | $2.05B | $2.61B | $1.63B | $1.59B | $1.46B |
| G&A Expenses | $1.38B | $1.22B | $1.16B | $1.00B | $0.74B |
| Total Operating Expenses | $3.43B | $3.83B | $2.79B | $2.60B | $2.25B |
| Operating Income | $1.34B | $0.10B | $0.66B | $0.59B | $0.59B |
| Operating Margin %(computed) | 26.12% | 2.39% | 17.73% | 17.43% | 19.62% |
| Interest Income | $0.11B | $0.13B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $1.66B | $0.32B | $0.83B | $0.53B | $0.57B |
| Income Tax Expense | $0.38B | $0.28B | $0.24B | $0.19B | ($0.38B) |
| Net Income | $1.29B | $0.03B | $0.60B | $0.34B | $0.95B |
| Net Margin %(computed) | 25.03% | 0.77% | 16.17% | 10.04% | 31.76% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $6.59 | $0.16 | $2.67 | $1.53 | $4.30 |
| Wtd Avg Shares | 0.20B | 0.21B | 0.22B | 0.22B | 0.22B |
| EBITDA | $1.76B | $0.41B | $0.92B | $0.60B | $0.63B |
| EBITDA Margin %(computed) | 34.24% | 9.62% | 24.88% | 17.66% | 21.10% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Incyte Corporation data
About Incyte Corporation (INCY) Income Statement
Incyte Corporation (INCY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, INCY reported revenue of $5.14B, gross profit of $4.77B (gross margin 92.76%), and net income of $1.29B — a net profit margin of 25.03%.
Frequently asked questions
INCY · 4 questionsIncyte Corporation (INCY) reported revenue of $5.14B for 2025, up 21.2% year-over-year.
INCY revenueINCY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08